Curant Health Partners with BioCareSD and LogiCare3PL to Offer Integrated, Enhanced Product & Patient Journey

29 August 2023

Curant Health, a prominent organization focused on patient support based on outcomes, has announced a strategic collaboration with BioCare Inc.'s subsidiaries: BioCareSD, a leading distributor of life-saving therapies, and LogiCare3PL, the third-party logistic solution by BioCare. This partnership aims to establish an advanced and streamlined single-source ecosystem tailored to cater to the intricate requirements of patients and products within the realm of rare diseases.

With over four decades of specialized distribution expertise and cutting-edge technologies at its disposal, BioCare is dedicated to ensuring that patients afflicted by rare diseases receive critical therapeutics precisely when they need them. The amalgamation of BioCareSD's expansive distribution network, LogiCare3PL's comprehensive logistic solutions, and Curant Health's industry-leading market access and patient support programs is poised to address the substantial unmet needs encountered by the rare disease community on a daily basis. Beyond simplifying the supply chain, this partnership will tap into exceptional performance benchmarks to guarantee the highest quality products and an unparalleled patient journey.

Jeff Beck, Chief Development Officer at BioCare, highlighted the significance of this collaboration in enhancing the efficiency of the prescription journey for individuals grappling with rare diseases. He underscored Curant Health's suitability as the ideal partner to navigate and bolster the patient journey.

Michell Butler, Senior Director of Clinical Services at Curant Health, expressed that the synergy with BioCareSD and LogiCare3PL will orchestrate seamless transitions for rare disease patients, circumventing numerous gaps that often hinder both the initiation and continuity of therapy. The ultimate measure of success, Butler emphasized, rests upon the patient outcomes. This collaborative endeavor is meticulously designed to tangibly elevate the patient experience while significantly enhancing the outcomes for biopharmaceutical partners.

 

Source: businesswire.com